Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol for Related Donor Hematopoietic Stem Cell Transplantation (HSCT) for Treatment of Symptomatic Genetic Lymphohematological Diseases

NCT02512679 is registered in ClinicalTrials.gov with Children's Hospital Los Angeles as lead sponsor.

NCT NCT02512679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02512679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol for Related Donor Hematopoietic Stem Cell Transplantation (HSCT) for Treatment of Symptomatic Genetic Lymphohematological Diseases
Lead sponsor
Children's Hospital Los Angeles
Phase
Phase 2
Overall status
Terminated
Start date
February 28, 2007
Completion date
February 28, 2014
Enrollment
20 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

allogeneic transplantation, bone marrow transplantation, chronic granulomatous disease, combined immune deficiency, diamond-blackfan anemia, genetic diseases, metabolic diseases, pediatrics, peripheral blood stem cell transplantation, stem cell transplantation, thalassemia, wiskott-aldrich syndrome, x-linked lymphoproliferative disease